CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-12 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −92 | $68.20 | $6K | 0 |
| 2023-07-12 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 196,000 | ||
| 2023-07-12 | Smith Brandon S. Chief Operating Officer | Option exercise 10b5-1 | +4,000 | $11.12 | $44K | 4,000 |
| 2023-07-12 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −3,200 | $67.40 | $216K | 800 |
| 2023-07-12 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −800 | $67.95 | $54K | 0 |
| 2023-07-12 | Smith Brandon S. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 230,667 | ||
| 2023-07-05 | Karp Carol D. Chief Regulatory Officer | Option exercise 10b5-1 | +5,000 | $12.15 | $61K | 5,000 |
| 2023-07-05 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −3,966 | $67.98 | $270K | 1,034 |
| 2023-07-05 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −1,034 | $68.69 | $71K | 0 |
| 2023-07-05 | Karp Carol D. Chief Regulatory Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 60,000 | ||
| 2023-07-05 | Zago Wagner M. Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $12.15 | $49K | 4,000 |
| 2023-07-05 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −2,991 | $67.98 | $203K | 1,009 |
| 2023-07-05 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −1,009 | $68.69 | $69K | 0 |
| 2023-07-05 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 62,000 | ||
| 2023-07-03 | Selkoe Dennis J. Director | Option exercise 10b5-1 | +5,000 | $11.33 | $57K | 7,845 |
| 2023-07-03 | Selkoe Dennis J. Director | Sale 10b5-1 | −5,000 | $67.43 | $337K | 2,845 |
| 2023-07-03 | Selkoe Dennis J. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 12,500 | ||
| 2023-06-28 | Malecek Michael J Chief Legal Officer | Option exercise 10b5-1 | +5,000 | $10.27 | $51K | 5,000 |
| 2023-06-28 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −1,240 | $69.07 | $86K | 3,760 |
| 2023-06-28 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −3,050 | $69.89 | $213K | 710 |
Page 11 of 41 · 819 trades